Just how prevalent are peptide therapeutic products? A critical review.
Just how prevalent are peptide therapeutic products? A critical review.
复制标题
DOI:
10.1016/j.ijpharm.2020.119491
复制
发表时间:
2020-09-25
影响因子:
5.8
通讯作者:
Williams, Robert O., III
中科院分区:
文献类型:
--
作者:
Zhang, Yajie;Zhang, Hairui;Ghosh, Debadyuti;Williams, Robert O., III
How prevalent are peptide therapeutic products? How innovative are the formulations used to deliver peptides? This review provides a critical analysis of therapeutic peptide products and the formulations approved by the United States Food and Drug administration (FDA), the European Medicines Agency (EMA), and the Japanese Pharmaceuticals and Medical Devices Agency (PMDA). This review also provides an in-depth analysis of dosage forms and administration routes for delivering peptide therapeutics, including injectables, oral dosage forms, and other routes of administration. We discuss the function of excipients in parenteral formulations in detail, since most peptide therapeutics are parenterally administered. We provide case studies of alternate delivery routes and dosage forms. Based on our analysis, therapeutic peptides administered as injectables remain the most commonly used dosage forms, particularly in the form of subcutaneous, intravenous, or intramuscular injections. In addition, therapeutic peptides are formulated to achieve prolonged release, often through the use of polymer carriers. The limited number of oral therapeutic peptide products and their poor absorption and subsequent low bioavailability indicate a need for new technologies to broaden the formulation design space. Therapeutic peptide products may also be delivered through other administration routes, including intranasal, implant, and sublingual routes. Therefore, an in-depth understanding of how therapeutic peptides are now formulated and administered is essential to improve peptide delivery, improve patient compliance, and reduce the healthcare burden for these crucial therapeutic agents.
登录
查看更多内容
影响因子:
3.8
作者:
Al-Hussein, Anas;Gieseler, Henning
通讯作者:
Gieseler, Henning
影响因子:
14.2
作者:
Bernstein, IL
通讯作者:
Bernstein, IL
影响因子:
3
作者:
Banks WA
通讯作者:
Banks WA
DOI:
10.1007/bf02996761
发表时间:
1998-01-01
期刊:
Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
影响因子:
--
作者:
Birdi, S M;Singh, S;Singh, A
通讯作者:
Singh, A
影响因子:
15
作者:
BALARAM, H;PRASAD, BVV;BALARAM, P
通讯作者:
BALARAM, P